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Abstract
Background: Colorectal cancer remains one of the most common malignant tumors worldwide. Colorectal cancer
initiating cells (CCICs) are a small subpopulation responsible for malignant behaviors of colorectal cancer. Aberrant
activation of the Wnt pathways regulates the self-renewal of CCIC. However, the underlying mechanism(s) remain
poorly understood.
Methods: Via retroviral library screening, we identified Nuclear Receptor-Interacting Protein 2 (NRIP2) as a novel
interactor of the Wnt pathway from enriched colorectal cancer colosphere cells. The expression levels of NRIP2 and
retinoic acid-related orphan receptor β (RORβ) were further examined by FISH, qRT-PCR, IHC and Western blot.
NRIP2 overexpressed and knockdown colorectal cancer cells were produced to study the role of NRIP2 in Wnt
pathway. We also verified the binding between NRIP2 and RORβ and investigated the effect of RORβ on CCICs
both in vitro and in vivo. Genechip-scanning speculated downstream target HBP1. Western blot, ChIP and luciferase
reporter were carried to investigate the interaction between NRIP2, RORβ, and HBP1.
Results: NRIP2 was significantly up-regulated in CCICs from both cell lines and primary colorectal cancer tissues.
Reinforced expression of NRIP2 increased Wnt activity, while silencing of NRIP2 attenuated Wnt activity. The
transcription factor RORβ was a key target through which NRIP2 regulated Wnt pathway activity. RORβ was a
transcriptional enhancer of inhibitor HBP1 of the Wnt pathway. NRIP2 prevented RORβ to bind with downstream
HBP1 promoter regions and reduced the transcription of HBP1. This, in turn, attenuated the HBP1-dependent
inhibition of TCF4-mediated transcription.
Conclusions: NRIP2 is a novel interactor of the Wnt pathway in colorectal cancer initiating cells. interactions
between NRIP2, RORβ, and HBP1 mediate a new mechanism for CCIC self-renewal via the Wnt activity.
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Background
Colorectal cancer remains one of the most common ma-
lignant tumors in the world [1]. Studies have indicated
that colorectal cancer consists of heterogeneous popula-
tions of cells differing in gene expression and growth
capacities [2, 3]. CCICs are a small subpopulation of
cells within colorectal tumors that can self-renew,
differentiate into multiple lineages, and drive tumor
growth [4, 5]. Among the CCIC properties, the self-
renewal ability, which allows the cells to replicate is a
crucial step for CCICs that is responsible for maintain-
ing their homeostasis and malignant behaviors [6–8]. It
is therefore of particular importance to clarify which
molecules are abnormally activated during CCIC self-
renewal.
There are several pathways participating in the regula-
tion of the self-renewal of CCICs. Notch signaling plays
an important role in promoting CCIC self-renewal. The
Notch effector Hes1 up-regulates the expression of the
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stem-related molecules CD133, ABCG2, Nanog, and
ALDH1 and increases the amount of CD133+ and stem-
like SP cells within colorectal cancer cells [9]. miR-34a
targeting Notch1 promotes the differentiation of CCICs
[10]; The BMP pathway maintains a stem cell self-
renewal balance by inhibiting the Wnt pathway. The
zinc-finger transcription factor GATA6 is a crucial regu-
lation factor connecting the Wnt and BMP pathways.
Competing with β-catenin/TCF4, GATA6 binds to a dis-
tal regulatory region of BMP4, decreases the threshold
of the BMP pathway and enables the self-renewal of
CCICs [11]. Colorectal cancer cells also have a high level
of activity of HedgeHog (HH)-GLI signaling, and the
self-renewal of CCICs relies on the direct function of
HH-GLI activity in xenograft tumors [12]; Akt can acti-
vate 14-3-3zeta in the beta-catenin complex, which con-
tributes to the stabilization and nuclear translocation of
β-catenin, thus facilitating CCSC self-renewal by activat-
ing Wnt [13]. Akt also phosphorylates Oct4 to promote
iPS factor transcription [14]. Among these pathways, the
abnormal activation of the Wnt pathway is one of the
most critical events in the tumorigenesis and develop-
ment of colorectal cancer and plays a key role in main-
taining the self-renewal of CCICs [15–18]. Aberrant
activation of the Wnt pathway occurs in >90% of colo-
rectal cancers [19]. Strong Wnt activation is found in
cancerous intestinal epithelial ALDH+ initiating cells in
ulcerative colitis in addition to CD133+ initiating cells in
animal tumorigenesis models [20, 21]. Hence, Wnt activ-
ity is an important target for inhibition of the self-
renewal of CCICs.
The Wnt pathways include canonical (β-catenin-
dependent) and non-canonical (β-catenin-independent)
pathways. In the canonical Wnt pathway, the ligands
Wnt1, Wnt3a, and Wnt8 can bind the Frizzled receptor
and LRP5/6 co-receptor on the cell surface, promoting
the recruitment of Disheveled (Dvl) from the cytoplasm
to the membrane. This, in turn, induces GSK-3β phos-
phorylation, which suppresses β-catenin degradation.
Free β-catenin then accumulates in the cytoplasm and
translocates to the nucleus, where it interacts with LEF
and TCF to activate the transcription of downstream tar-
gets, including MYC, CCND1, AXIN2, and LECT2, etc.
[22, 23]. The non-canonical pathways mainly include the
PCP pathway and Wnt/Ca2+ pathway. In the PCP path-
way, Wnt5a and other ligands bind to Frizzled and
ROR2/PTK7 co-receptors, inducing a signaling cascade
involving RhoA, Rac, Cdc42, and JNK, which act on the
cytoskeleton [24, 25]. In the Wnt/Ca2+ pathway, Wnt
ligands combine with Frizzled, leading to PKC and
CamKII activation, which regulate target transcription
[26, 27]. Thus, the non-canonical Wnt pathways main-
tain the self-renewal capacity of tumor cells and pro-
mote their tumorigenic ability by influencing canonical
Wnt pathway activation at different levels [19, 26]. How-
ever, the mechanism of Wnt pathway activation in
CCICs is still unclear; especially in terms of how non-
canonical Wnt signaling molecules affect the canonical
pathway.
Here, we identified NRIP2 as a novel molecule that
collaborates with RORβ and HMG box-containing
protein 1 (HBP1) to modulate Wnt activity.
Methods
Cancer tissues and cDNA database
All fresh primary colorectal cancer tissues were collected in
the Second Affiliated Hospital of the Zhejiang University
School of Medicine, with Institutional Review Board
approval and informed consent provided by the patients
(Reference number: R2014-041). All 565 cDNA genechip
databases derived from patients with colorectal cancer were
from the City of Hope National Medical Center of USA.
Cell culture
Colorectal cancer SW620, HT29, and LoVo cells; gastric
cancer SGC7901 cells; and 293 T cells were purchased
from The Cell Bank of Chinese Academy of Sciences at
the Shanghai Institute of Cell Biology. Colorectal cancer
cells which were derived from primary colorectal cancer
tissue were cultured in DMEM/F12 medium (Gibco,
Gaithersburg, MD, USA) [28]; SW620 cells were cul-
tured in L-15 medium (Gibco); HT29 cells were cultured
in Macoy’s 5A medium (Gibco); Lovo cells were cultured
in F-12 medium (Gibco); SGC7901 and P1 cells were
cultured in RPMI-1640 medium (Cellgro, Manassas,
USA); and 293 T cells were cultured in DMEM high-
glucose medium (Gibco). All media were supplemented
with 100 U/ml penicillin, 100 μg/ml streptomycin, and
10% fetal bovine serum (Gibco). The cells were cultured
at 37 °C in a humidified atmosphere containing 5% CO2.
Culturing and counting spheres
Colorectal cancer cell lines and primary colorectal
cancer cells were seeded into 24-well low-adhesion
plates (Corning, NY, USA) at 200 cells/well and cultured
in serum-free sphere medium (containing 1× B27, 20 μg/L
EGF, 20 μg/L bFGF, 4 mg/L insulin, 0.4% BSA, and
200 IU/mL streptomycin). These cells were grown in the
presence or absence of Wnt Pathway Inhibitor XI, Wnt/
β-catenin Inhibitor, Cardamonin (Merck, Germany), or
the Wnt activator recombinant Wnt3a (R&D Systems,
MN, USA) for 7–14 days at 37 °C in a humidified
atmosphere containing 5% CO2. After the incubation
period, the spheres were dilute passaged for an add-
itional 1 week and the number of spheres was counted
manually.
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Organoid culture
The above colosphere cells were digested with 0.25%
trypsin and produced single cells using a 40 μM cell
strainer (BD, USA). One-hundred cells in 40 μL of
medium were mixed well with 70 μL of growth factor-
deficient Matrigel (Biocoat, USA) and inoculated on the
rim of a 24-well plate at 37 °C for 1 h. Subsequently,
1 mL of serum-free sphere medium was added for 5–7
days in a humidified atmosphere containing 5% CO2.
Creation and screening of a retroviral cDNA library
Total RNA was extracted from SW620 colosphere cells
using an RNeasy Kit (Qiagen, Germany). A ZAP cDNA
Library Preparation Kit (Stratagene, CA, USA) was used
to prepare cDNA, according to the manufacturer’s in-
structions. Briefly, RNA was reverse transcribed using a
ZAP hemi-methylation primer. Next, double-stranded
cDNA was synthesized in vitro, digested with XhoI/
EcoRI endonucleases, cloned into the modified pLXSN
vector (Clontech Laboratories, CA, USA), and trans-
formed into Escherichia coli DH5α cells (Stratagene).
The plasmids were then extracted and transfected into
PT67 packaging cells (Clontech) to produce the recom-
binant retroviral particles. Before infection, CD133+ and
CD44+ SGC7901 cells were removed by magnetic-
activated cell sorting (Miltenyi, Germany), and the
remaining SGC7901 cells were infected (multiplicity of
infection is 20) and cultured in a serum-free low adhe-
sion culture system for 7 days. Colospheres were then
collected and digested into a single cell suspension and
cloned by limiting dilution, and the clonal cells were
further propagated. The Top/Fop flash reporter assay
was used to determine Wnt activity. Genomic DNA
from cells with obvious changes in Wnt activity was ex-
tracted using a DNA extraction kit (Qiagen, Germany),
and PCR was used to amplify the inserted DNA frag-
ment with primers from pLXSN plasmids. Finally, DNA
sequencing was performed to verify the clones.
mRNA hybridization
A QuantiGene @ ViewRNA ISH Tissue Assay Kit
(Affymetrix, USA) was used for RNA hybridization ac-
cording to the kit instructions. Briefly, RORB and NRIP2
were used as TYPE1 probes, and GAPDH was used as a
control probe. After staining the nucleus with DAPI or
Hoechst 33342 dye (Invitrogen, Carlsbad, CA), the distri-
bution and expression of RORB and NRIP2 were observed
under a confocal microscope (Carl Zeiss Jena, Germany).
Assessing tumor sizes in mice
With approval from a local animal protection associ-
ation, NOD/SCID and naked Balb/c mice were pur-
chased from the Shanghai Laboratory Animal Center
(Chinese Academy of Sciences) and bred in specific
pathogen-free animal housing at the Laboratory Animal
Research Center (Zhejiang Traditional Chinese Medical
University). The mice were randomized into groups (5
mice/group for each tumor cell dose) and subcutane-
ously inoculated in their backs with 0.3 mL of different
numbers of SW620 cells. The formation and growth of
the transplanted tumors were observed, and the tumor
sizes were recorded. The tumor volumes were calculated
as 4/3π [1/2 × (long diameter/2 + short diameter/2)]3.
Measuring Wnt pathway activity
Wild-type and mutant plasmids were co-transfected
with Top/Fop flash reporters (Millipore, Germany) and
the pRL plasmid as an internal reference (ratio of
3:1:0.1). The cells were harvested after 24–48 h, washed
twice with phosphate-buffered saline (PBS), lysed in lysis
buffer (Promega, Madison, WI, USA), and centrifuged at
13,000 rpm for 1 min. The luciferase activities were
measured in the lysate supernatants using the Dual-
Luciferase Reporter Assay System (Promega).
Co-Immunoprecipitation and western blot analysis
For Co-IP studies, cells were harvested; incubated on ice
for 15 min with 200 μl of RIPA lysis buffer containing
1% NP-40, 0.25% deoxycholic acid, 5 mM Dithiothreitol
(DTT), and 1× protease inhibitor cocktail (Merck, NJ,
USA); and centrifuged for 10 min at 13,000 rpm. The
supernatants were collected and incubated with 5 μg of
primary antibody for 2 h at 4 °C, then incubated over-
night at 4 °C with 50 μl protein A/G-Agarose beads
(Santa Cruz Biotechnology, Santa Cruz, CA, USA), and
centrifuged at 13,000 rpm for 10 min. The beads were
washed with lysis buffer and centrifuged 5 times. Subse-
quently, 50 μl of loading buffer was added to the beads
and the samples were heated for 3 min in a water bath
at 100 °C, cooled to room temperature (RT), and centri-
fuged for 1 min at 13,000 rpm. The resulting superna-
tants were collected for western blot analysis.
For western blot analysis, the cells were harvested and
incubated on ice for 15 min with 200 μl of RIPA lysis buf-
fer containing 1% NP-40, 0.25% deoxycholic acid, 5 mM
DTT, and 1× protease inhibitor cocktail (Merck, NJ,
USA). The lysates were centrifuged for 10 min at
13,000 rpm, and the supernatants were collected. The
samples were mixed with 2× loading buffer, heated for
3 min in a 100 °C water bath, cooled to RT, and subjected
to SDS-PAGE. The proteins were then transferred to a
nitrocellulose membrane (Whatman, Dassel, Germany),
blocked for 1 h at RT with Tris-base buffer saline +0.05%
Tween 20 (TBST) buffer containing 5% skim milk, and
then incubated with a primary antibody for 1 h at RT or
overnight at 4 °C. Primary antibodies against the following
target proteins were used in this study: NRIP2, HBP1
(1:1,000; Novus, USA), cyclin D1, c-Myc, RARα, RORβ
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(1:1000–2000; Epitomics, CA, USA), and GAPDH
(1:5000; KangChen Biotech, Shanghai, China). The nitro-
cellulose membrane was washed with TBST and then
incubated with a secondary antibody (HRP-labeled goat
anti-rabbit antibody or HRP-labeled goat anti-mouse anti-
body, 1:2000, Cell Signaling Technology, Danvers, MA,
USA) for 1 h at RT. Bands were visualized by exposing the
membranes to ECL reagent (Cell Signaling Technology).
Immunohistochemical staining
Following approval by the Ethics Committee of The Sec-
ond Affiliated Hospital of the Zhejiang University School
of Medicine, histological sections of colorectal cancer
tissues were incubated overnight at 60 °C, fully hydrated
with xylene and gradient alcohol, placed in antigen
retrieval solution (pH 8.0, 100 mM EDTA), and heated for
15 min. Subsequently, the sections were cooled to RT,
washed 3 times in TBST, blocked for 20 min at RT with
TBST containing 10% goat serum, and washed 3 times in
TBST. Sections were incubated overnight at 4 °C with an
anti-NRIP2 antibody (1:1000, Novus, CO, USA), an anti-
RORβ antibody (1:250, Novus, USA). After incubation
with the primary antibody, the sections were washed 3
times in TBST and incubated for 1 h at RT with a second-
ary rabbit antibody (1:200; Dako, Denmark). The sections
were developed with 3,3′-diaminobenzidine, counter-
stained with hematoxylin, and examined by microscopy.
Lentivirus infection
For NRIP2 or RORβ over-expression, colorectal cancer
cells were infected for 24 h with recombinant lentivirus
encoding human NRIP2 or RORB (Shanghai Innovation
Biotechnology Co. for NRIP2 and Shanghai Ruisai Bio-
technology Co. for RORB); meanwhile, the cells were
infected with blank vector lentivirus as a control. For
target gene knockdown, colorectal cancer cells were in-
fected for 72 h with lentivirus encoding shRNAs against
NRIP2, RORB, or HBP1 or with scrambled shRNA as a
control (Santa Cruz Biotechnology). Subsequently, cells
were selected in puromycin (5 μg/ml) for 2 weeks.
Clonal cells stably expressing shRNAs were cultured by
limiting dilution, and the efficiency of target gene knock-
down was verified by western blot analysis.
Construction of NRIP2 and RORB plasmids
The NRIP2 ORF DNA sequence (Genbank access:
AL136557) was synthesized by the Shanghai Xuguan Bio-
technology Development Co. Ltd. and cloned into the
pUC57 vector (Thermoscientific, MA USA). The RORB/
pReceiver plasmid was purchased from Fulengen Co. Ltd
(Guangzhou, China). Subsequently, the NRIP2 and RORB
ORF DNA sequences were subcloned into the pEGFP-C1
vector at the XhoI and BamHI sites, respectively. Con-
structs were confirmed by DNA sequencing.
RT-PCR and RT-qPCR
Total RNA was extracted from cells receiving different
treatments using a RNA mini kit (Qiagen, Germany).
After the quantity of RNA was checked, the RNA was
reversed transcribed to cDNA by PrimeScript™ reverse
transcriptase with a gDNA eraser kit (Takara, Japan).
RT-PCR and Taqman RT-qPCR were carried out using
the Premix EX Taq™ hot start version PCR and Perfect
Real Time PCR kits following the manufacturer’s in-
structions. The primers used are as below: NRIP2: 5′-
cacaggcacccaatacaatc-3′(Forward), 5′-tgtagctccaactgct c
cac-3′ (Reverse), 5′Fam-ccaggcggctgagacatcca-3′Tamra
(Probe); RORB: 5′-gcttcttattcctgcccaag-3′(Forward), 5′-
cttggacatcctcccaaact-3′(Reverse), 5′Fam-aaccgttgccaaca
ctgccg-3′Tamra (Probe); GAPDH: 5′-atcatccctgcc tct
actgg-3′ (Forward), 5′-gtcaggtccaccactgacac-3′(Reverse),
5′Fam-accttgc ccacagccttggc-3′ Tamra (Probe).
Gene chip detection
SGC7901 cells were transiently transfected with RORB/
pReceiver plasmids (Fulengen) using Lipofectamine 2000
reagent (Invitrogen, USA) for 48 h. The cells were lysed
by the addition of 1 mL of Trizol reagent (BBI, Canada),
and total RNA was extracted. A GeneChip® PrimeView™
Human Gene Expression Array (Affymetrix, USA) was
used to detect global mRNA expression profiles. Differ-
ences in mRNA expression were verified by RT-qPCR.
Chromatin immunoprecipitation
A commercial kit (Upstate, Millipore, USA) was used to
perform ChIP assays according to the manufacturer’s
instructions. In brief, SGC7901 cells were seeded in a 100-
mm dish at 70% confluency overnight and subsequently
transiently transfected with RORB/pReceiver plasmids for
an additional 48 h. Transfected cells were fixed by a final
concentration of 1% formaldehyde for 10 min; the reac-
tion was terminated by adding 0.5 mL of 1 M glycine solu-
tion. The cells were collected and lysed by SDS reagent.
The DNA fragments were co-immunoprecipitated by
anti-myc tag antibodies in agarose at 4 °C overnight after
sonication. The immunoprecipitated DNA fragments were
purified and eluted by the spin filter method. PCR was
used for the detection of the HBP1 upstream DNA frag-
ments with the primers: Forward:5’-gtcctttgcaggacatggat-3’,
Reverse: 5’-gtgccatggaggtttgctat-3’. Blank, normal mouse
IgG was used as a negative control, and anti-RNA poly-
merase II was used as a positive control.
EMSA
An Electrophoretic Mobility Shift Assay (EMSA) kit
(Pierce, Thermo Scientific, USA) was used to perform
EMSA assays according to the manufacturer’s instructions.
DNA sequences of the wild-type and mutant hormone
response elements were chemically synthesized. Upstream
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and downstream DNA primers (100 μM) were mixed and
incubated at 94 °C in vitro for 5 min and allowed to cool to
RT. The probe was incubated with recombinant RORβ for
30 min and resolved on a 6% PAGE gel. The DNA was then
transferred to a nylon membrane and crosslinked for
1 min, after which HRP-labeled streptavidin was added for
30 min and an enhanced ECL reagent was used for detec-
tion. WT: 5’-Bio-gatcacgaggtcaagagatcgagaccatcctg-3’(For-
ward), 5’-Bio-caggatggtctcgatctcttgacctcgtgatc-3’ (Reverse);
Mut1:5’-Bio-gatcacg aggtcaagaccatcctg-3’ (Forward), 5’-Bio-
caggatggtcttgacctcgtgatc-3’ (Reverse); Mut2: 5’-Bio-gatcac-
gaggtcaagagatcgtcctg-3’ (Forward), 5’-Bio-caggacgatct cttga
cctcgtgatc-3’ (Reverse); Mut3: 5’-Bio-gatcacgagagatcgagac-
catcctg -3’ (Forward), 5’-Bio-caggatggtctcgatctctcgtgatc-3’
(Reverse).
Construction and transfection of the HBP1 promoter/
pGL3 luciferase reporter vector
Bioinformatics analysis of the human HBP1 5′ flanking
region was used to design the following PCR primers:
5′-agtcactgagctctgtcccagacaccaaaacaa-3′ (forward) and
5′-agtcactctcgagcggcagctcttactcctcaa-3′ (reverse). DNA
from SW620 cells was used as a template. The ~2,500 bp
promoter region of the HBP1 gene was amplified using
35 cycles of 95 °C for 10 s, 55 °C for 15 s, and 72 °C for
150 s. The PCR product was doubly digested with XhoI
and SacI enzymes and inserted into the pGL3-basic vector
(Promega), creating a luciferase reporter gene vector con-
taining the HBP1 promoter region (pGL3-HBP1). The
primers used to construct the HBP1 gene promoter
reporter vector containing hormone response elements
were as follows: 5′-agtcactctcgagcggcagctcttactcctcaa-3′
(forward) and 5′-agtcactgagc tcggaggatcacgaggtcaagagat
cgagaccatcctggtgtcccagacaccaaaacaa-3′ (reverse). Plasmid
DNA containing the HBP1 promoter was used as a tem-
plate for PCR, with 10 cycles of (95 °C for 10 s, 58.8 °C for
15 s, and 72 °C for 40 s) and 20 cycles of (95 °C for 10 s,
69.0 °C for 15 s, and 72 °C for 40 s). The PCR prod-
uct was doubly digested with XhoI and SacI enzymes
and inserted into the pGL3-basic vector, creating a
HBP1 promoter reporter vector containing hormone
response elements.
The pGL3-HBP1, RORB-pCMV6/XL4, and pRL
plasmids (an internal reference) were co-transfected
(1:3:0.1) by Lipofectamine 2000 reagent into SGC7901
tumor cells for 24 h. The cells were collected and
washed twice in 0.01 M PBS (pH7.4) and lysed in
lysis buffer (Promega, Madison, WI, USA). The cell
lysates were centrifuged at 13,000 rpm for 1 min, and
the supernatants were collected for the measurement
of luciferase activity. The pGL3-basic, pCMV6/XL4,
and pRL plasmids were co-transfected (1:3:0.1) in
control experiments.
Statistical analysis
Continuous variables were expressed as the mean ±
standard deviation (SD). Single factor analysis of vari-
ance and t tests were used to compare multiple groups
of independent samples or paired samples. The level of
significance was set as p <0.05. Statistical analysis was
performed using SPSS 18 (SPSS Inc., Chicago, IL, USA).
Results
Wnt activity is important for the self-renewal of CCICs
To evaluate the effect of Wnt activity on CCIC self-
renewal, we first enriched colospheres in vitro from pri-
mary colorectal cancer tissues and colorectal cancer cell
lines and identified their stem-like properties. Using
serum-free, low-adhesion culture conditions, colospheres
were successfully enriched and dilute passaged from 3 pri-
mary colorectal cancer cells as well as colorectal cancer-
derived HT29 and SW620 cells. Furthermore, single cells
from these spheres were able to form organoids in the
conditioned Matrigel medium (Fig. 1a). These colospheres
were inoculated into NOD/SCID mice, and they exhibited
significantly increased tumorigenicity (Fig. 1b). These re-
sults suggested that the enriched colospheres possessed
cancer-initiating cell properties. Next, we assayed for Wnt
activity in the colosphere cells. Both Top/Fop flash re-
porter assays and western blots indicated that these colo-
sphere cells had relatively strong Wnt activity compared
with their parental cells (Fig. 1c and d). Finally, we evalu-
ated the effect of Wnt pathway activation on the self-
renewal capacity of CCICs. The number of colospheres
was obviously increased after Wnt signaling was activated
by the addition of recombinant Wnt3a (Fig. 1e). However,
the number of colospheres significantly decreased in pri-
mary colorectal cancer P1, HT-29, and SW620 cells after
CTNNB1 was knocked down by RNA interference
(Fig. 1f). Treatment with Wnt and β-catenin chemical in-
hibitors showed similar results (Fig. 1g). Collectively, these
results suggested that activation of the Wnt pathway plays
an important role in the self-renewal capacity of CCICs.
NRIP2 is significantly up-regulated in CCICs
The above results demonstrated that Wnt pathway
activation plays an important role in maintaining the
self-renewal of CCICs; however, the molecular mecha-
nisms whereby Wnt pathway activation occurs in
CCICs remain unclear. To screen molecular activators
of the Wnt pathway, we constructed a retroviral
cDNA library from SW620 colosphere cells and
screened it by colosphere formation and Top/Fop
flash reporter assays as well as DNA sequencing
(Fig. 2a). Based on these screening strategies, there
were 13 candidates from SW620 colosphere cells
identified by DNA sequencing (Additional file 1:
Figure S2a). We found that among these candidates,
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only the function of NRIP2 was undefined for pro-
moting the self-renewal of colosphere cells.
Western blot analysis showed that NRIP2 was
expressed in primary colorectal P1, HT29, and SW620
cells (Fig. 2b, Additional file 1: Figure S2b). The pres-
ence of NRIP2 in primary tumor cells was confirmed by
mRNA fluorescence in situ hybridization (FISH) and
immunohistochemical (IHC) staining (Fig. 2c and d).
To verify that NRIP2 is expressed at a higher level in
CCICs, we isolated CD44+CD24+ colorectal cancer-
initiating cells from primary colorectal P1 and SW620
cells by fluorescence-activated cell sorting (FACS) and
colospheres from colorectal cancer cell lines and primary
colorectal cancer tissues. RT-qPCR analysis showed that
NRIP2 expression was significantly higher in CD44+CD24+
cells and colosphere cells (Fig. 2e-g). Similar results were
observed in CD133+ and Aldefluor+ colorectal cells
(Additional file 1: Figure S2c and S2d). On the other hand,
we analyzed the relationship between NRIP2 expression
and colorectal cancer molecular typing in 565 cases
of colorectal cancer from a global cDNA expression
genechip database and found that high NRIP2 expres-
sion was closely related to the C4-cancer stem cell
(CSC) subtype of colorectal cancer (Fig. 2h) [29].
Gene set enrichment analysis (GSEA) also showed
that in colorectal cancer cells expressing high levels
Fig. 1 Wnt activity is important for the self-renewal of CCICs. a Colospheres were enriched from 3 primary colorectal cancer tissues, colorectal cancer
HT29 cells, and SW620 cells on the 5th day in low-adhesive and serum-free culture medium. Colosphere formation occurred after the serial dilution of
cells on the 5th day. Single colosphere cells formed organoids in growth factor-deficient Matrigel medium at the 5-7th day (bottom). b Tumorigenicity
of colospheres. Different numbers of colosphere cells from primary colorectal cancer tissues (P1 cells) were injected into NOD/SCID mice and tumor
formation was quantified after 8 weeks. The results showed that colospheres exhibited significantly increased tumorigenicity (p < 0.05, Multivariate
logistic analysis). The same number of parental cells was used as a control. c Wnt activity in colospheres. Colosphere or parental cells (control) were
transfected with Top/Fop flash reporters, and the Wnt pathway activity was determined at 24 h post-transfection. The fold-change was calculated
relative to controls. The values are represented as the mean ± SD from triplicate samples. *p < 0.05; **p < 0.01; ***p < 0.001 (ANOVA). d The levels of
Wnt signaling downstream of c-Myc were detected by western blotting in HT29, P1 and SW620 colospheres (Spheres), with their parental cells as
controls. e Quantification of organoid formation after Wnt pathway activation. The number of organoids was counted from 3 primary colorectal cancer
cells (100 cells/well) by the treatment of recombinant Wnt3a (200 ng/mL) for 7 days; cells without treatment of Wnt3a were used as controls. The
number of organoids significantly increased after Wnt pathway activation. *p < 0.05 (ANOVA). f Quantification of colosphere formation after CTNNB1
knockdown. The colosphere number was counted in CTNNB1-knockdown HT29, P1, and SW620 cells under low-adhesive and serum-free conditions
for 7 days. The colosphere number significantly decreased in these cells after knockdown of CTNNB1. **p < 0.01; ***p < 0.001 (ANOVA). g Quantification
of colosphere formation after Wnt pathway inactivation. Colospheres were counted in HT29, P1, and SW620 cells treated with Wnt inhibitor (7.2 μM) or
β-catenin inhibitor (3.6 μM) for 7 days, with the solvent dimethyl sulphoxide (DMSO) as a control. The colosphere number significantly decreased after
the inhibition of Wnt activity. *p < 0.05; **p < 0.01; (ANOVA)
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of NRIP2, the alteration of the mRNA expression pro-
files was similar to that observed with low- and
intermediate-CpG-density promoters bearing the his-
tone H3 trimethylation marker at K4 and K27
(H3K4me3 and H3K27me3) in embryonic stem cells
(ES) and induced pluripotent cells (iPS) (Fig. 2i).
These results suggested that NRIP2 may play an im-
portant role in the self-renewal of CCICs.
NRIP2 up-regulates Wnt pathway activity
To characterize the relationship between NRIP2 and
Wnt activity, we determined the impact of NRIP2 on
Fig. 2 NRIP2 is significantly upregulated in CCICs. a Screening strategy for NRIP2. NRIP2 was identified in a screen for colosphere formation using a
retroviral cDNA expression library constructed from SW620 colosphere RNA (as detailed in the Materials and Methods). b NRIP2 expression in
colorectal cancer cells. NRIP2 was detected by western blotting in colorectal cancer cells. The results showed that P1, HT29, and SW620 cells expressed
NRIP2. c NRIP2 mRNA hybridization. Slides containing primary colorectal cancer tissue and normal colorectal tissue were hybridized with labeled
probes for NRIP2 mRNA respectively, with a nonsense probe as a negative control. FISH analysis showed NRIP2 expression in primary colorectal cancer
cells. d Expression of NRIP2 in primary colorectal cancer tissue. Colorectal cancer cells were reacted with antibodies against NRIP2 and subsequently
detected by IHC staining. Normal rabbit IgG was used as a negative control. e NRIP2 increased in CD44 + CD24+ cancer cells. NRIP2 mRNA levels were
determined by Taqman RT-qPCR in CD44 + CD24+ and CD44-CD24- FACS-isolated cells. NRIP2 expression increased in CD44 + CD24+ cells compared
with CD44-CD24- cells; *p < 0.05 (ANOVA). f NRIP2 expression in colospheres from colorectal cancer cells. NRIP2 levels were determined by Taqman
RT-qPCR in colospheres from P1, HT29, RKO, and SW620 cells under low-adhesive and serum-free conditions for 7 days. NRIP2 mRNA expression was
significantly higher in colospheres than in parental cells. *p < 0.05; ***p < 0.001 (ANOVA). g NRIP2 expression in colospheres from primary colorectal
cancer cells. NRIP2 levels were determined by Taqman RT-qPCR in colospheres from primary colorectal cancer samples under low-adhesive and
serum-free conditions for 7 days. NRIP2 mRNA expression was significantly higher in colospheres than in their parental cells. *p < 0.05; **p < 0.01;
***p < 0.001 (ANOVA). h Analysis of the relationship between NRIP2 and the colorectal cancer subtypes. The relationship between NRIP2 expression
and colorectal cancer molecular typing was analyzed by the global cDNA expression GeneChip database (n = 565). NRIP2 expression was closely related
to the C4-cancer stem cell (CSC) and C6-CIN colorectal cancer subtypes. C4 vs C2 or C3, all p < 0.05; C4 vs C2 or C3, all p < 0.01. i GSEA analysis. GSEA
analysis from primary colorectal cancer tissues with a high level of NRIP2 expression (n = 200). Similar alterations in the mRNA expression profiles were
found in cases with high levels of NRIP2 expression and in ES cells with histone methylation or iPS cells without histone methylation
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Wnt activity in HT29, P1 and SW620 cells. Western
blots showed that the Wnt pathway downstream targets
were significantly increased in cells after overexpression
of NRIP2, while it was obviously decreased after silencing
of NRIP2 in these cells (Fig. 3a and b, Additional file 1:
Figure S3). Furthermore, the colosphere numbers were
significantly attenuated in NRIP2- overexpressing HT29
and P1 cells after silencing of NRIP2 (Fig. 3c). Finally, we
evaluated whether NRIP2 promoted the self-renewal of
CCICs dependent on Wnt activation. To this end, we ob-
served a change in the colosphere number in NRIP2-
overexpressing cells after inactivation of Wnt. The results
showed that NRIP2 overexpression did not reverse
the inhibition caused by Wnt- and β-catenin chemical
inhibitors (Fig. 3d). NRIP2 overexpressing cells were
inoculated into NOD/SCID mice, and they exhibited
significantly increased tumorigenicity (Fig. 3e). To-
gether, these findings suggested that NRIP2 involves
in the self-renewal of colorectal cancer cells by acti-
vating the Wnt pathway.
NRIP2 regulates the activity of the Wnt pathway via RORβ
To discover downstream target molecules by which
NRIP2 regulates the Wnt pathway, we performed a
literature review and target prediction (www.genecards.
org) and found that NRIP2 can interact with RORβ [30].
Thus, we performed Co-IP and western blot analysis
with cells overexpressing NRIP2 and RORβ. The results
confirmed that both exogenous and endogenous NRIP2
could be co-immunoprecipitated with RORβ (Fig. 4a
and b), but NRIP2 could not bind to RARα (Additional
file 1: Figure S4). These results suggest that NRIP2 may
be involved in the Wnt pathway.
Although NRIP2 can interact with RORβ, it is not
clear whether RORβ affects Wnt pathway activity.
Therefore, we transiently expressed RORβ in SGC7901
cells, which had the highest transfection efficiency. The
results from Top/Fop flash assays and western blots
showed that the activity of the Wnt pathway was signifi-
cantly inhibited by RORβ overexpression (Fig. 4c and d).
To determine whether NRIP2 activates the Wnt pathway
dependent on RORβ, we established RORB-knockdown
cells and checked the effect of NRIP2 on these cells. The
results showed that NRIP2 could not activate the Wnt
pathway after knockdown of RORB (Fig. 4e and f). To-
gether, these results suggested that RORβ is an inhibitor
of the Wnt pathway and that NRIP2 may affect Wnt
pathway activity via RORβ.
Fig. 3 NRIP2 up-regulates Wnt pathway activity. a Over-expression of NRIP2 up-regulates Wnt pathway activity. c-Myc and cyclin D1 were
detected by western blotting in HT29, P1, and SW620 cells infected with recombinant lentivirus encoding NRIP2 with Myc-Tag, with cells infected
with blank lentivirus as controls. b Wnt activity in NRIP2-knockdown cells. c-Myc and cyclin D1 were detected by western blotting in NRIP2-
knockdown HT29, P1, and SW620 cells and their scrambled shRNA-treated cells (controls). c Quantification of colospheres after NRIP2 silence. The
number of colospheres was counted in Nrip2-expressing HT29 and P1 cells after NRIP2 silence. The number of colospheres significantly decreased
after silence of NRIP2, *p < 0.05 (ANOVA). Transfection with RNAi scramble as controls. d Quantification of colospheres in NRIP2-overexpressing
cells after Wnt inactivation. Colospheres were counted in NRIP2-overexpressing HT29, P1, and SW620 cells and controls treated with Wnt (7.2 μM)
and β-catenin inhibitors (3.6 μM). The colosphere number significantly decreased in NRIP2-overexpressing cells after Wnt inactivation. *p < 0.05;
**p < 0.01 (ANOVA). e Tumorigenicity of NRIP2- overexpressing cells. NRIP2- overexpressing P1 and HT29 cells and their control cells infected with
blank lentivirus were injected into naked Balb/c mice, respectively. Tumor formation was quantified within 4 weeks. The results showed that
overexpression of NRIP2 significantly increased tumorigenicity (# p < 0.05, Multivariate logistic analysis)
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RORβ inhibits tumorigenesis and the self-renewal of
CCICs
Previous studies have demonstrated that RORβ is mainly
distributed in the central nervous system [31, 32], how-
ever, whether RORβ is also expressed in intestinal epithe-
lial cells is unverified. To confirm that RORβ is expressed
in intestinal epithelial tissue, we evaluated RORβ expres-
sion in colorectal cancer cells by RT-qPCR and western
blotting. Immunostaining of RORβ was also carried out in
human primary colorectal cancer tissues. We also exam-
ined RORB mRNA expression in primary colorectal
cancer tissues by RT-qPCR and mRNA FISH. We found
that RORB was expressed in colorectal cancer cells, but at
a lower level in colorectal cancer tissue than in matched
para-carcinoma tissues (Fig. 5a-c, Additional file 1:
Figure S5). The level of RORB in CCICs was not sig-
nificantly different from their parental cells (data not
shown). To further clarify the effect of RORβ on CCICs,
we observed the tumorigenicity in vivo, the change in the
colosphere number and the ratios of CD44 + CD24+
cancer-initiating cells in cells with overexpression of
RORβ. The results showed that the tumorigenic capacity
was significantly reduced (Fig. 5d), the sphere-forming ef-
ficiency was decreased and the ratio of CD44+CD24+ cells
and the number of colospheres were also obviously
reduced in colorectal cancer cells after overexpression of
RORβ (Fig. 5e and f). Inversely, RORB knockdown led to
increased colosphere formation (Fig. 5g and h). These
results suggested that RORβ negatively regulates the self-
renewal of CCICs as a suppressor.
HBP1 is a crucial target of RORβ in regulation of the Wnt
pathway
To investigate how RORβ inhibits Wnt activation, we first
analyzed changes in mRNA expression in cells overex-
pressing RORβ. Genechip-scanning experiments showed
that HBP1, a protein that blocks TCF binding to DNA
[33], was significantly increased in cells overexpressing
RORβ (Fig. 6a). This result was subsequently confirmed
by western blot analysis (Fig. 6b). However, HBP1 obvi-
ously reduced following RORB silencing (Fig. 6c). Simi-
liarly, HBP1 was also reduced in the CCICs and crypts of
intestinal mucosa from Rorb−/− mice (Additional file 1:
Figures S6 and S7a). These results suggest that HBP1 is a
downstream target of RORβ. Furthermore, Chromatin Im-
munoprecipitation (ChIP) experiments showed that RORβ
could bind to HBP1 upstream DNA sequences (Fig. 6d).
Next, the upstream promoter region sequences of HBP1
Fig. 4 NRIP2 regulates the activity of the Wnt pathway via RORβ. a Analysis of NRIP2 binding to RORβ. Lysates from NRIP2-overexpressing SGC cancer
cells or control cells were subjected to co-IP with myc-tag antibody agarose beads, followed by western blotting with anti-RORβ antibodies. Normal
rabbit IgG agarose beads were used as a negative control. b Endogenous NRIP2 interacts with RORβ. Lysates from P1 cells without treatment with
protease inhibitor cocktails were subjected to co-immunoprecipitation with RORβ antibodies or mouse IgG (control), followed by western blotting with
anti-NRIP2 antibodies. Normal rabbit IgG agarose beads were used as a negative control. c Wnt activity in RORβ-expressing cells. Wnt activity was
assessed by Top/Fop flash reporter assays in SGC7901 cells 24 h after transient transfection with RORB or control plasmids. Overexpression of RORβ
attenuated Wnt activity. *p < 0.05 (ANOVA). d Detection of Wnt dowmstream targets in RORβ-expressing cells. c-Myc and cyclin D1 were detected by
western blotting in the above RORβ-overexpressing SGC7901 and control cells. e Detection of RORβ in RORB-knockdown cells. Cells were infected with
lentivirus encoding RORB shRNA for 72 h and subsequently screened with 5 μg/mL Puromycin for 7 days. The surviving cell clone was picked out with
limiting dilution analyses. RORβ was detected by western blotting in these RORB-knockdown clones, with cells infected with scrambled shRNA
lentivirus as controls. f NRIP2 failed to activate the Wnt pathway in RORB-knockdown cells. Wnt activity was assessed by Top/Fop flash reporter assays
in RORB-knockdown SGC7901 cell clones 24 h after transient transfection with NRIP2 or control plasmids. NRIP2 could not activate the Wnt pathway
after knockdown of RORB. *p < 0.05 (ANOVA), ns: non-significance, p > 0.05 (ANOVA)
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were analyzed, and several RORβ binding sequences were
identified (Additional file 1: Figure S7b), EMSA detection
confirmed that the HRE sequence AGGTCA is essential
for RORβ binding to the HBP1 promoter region (Fig. 6e).
By co-transfecting a RORB plasmid and a reporter encod-
ing luciferase under the control of the HBP1 promoter re-
gion sequences, we found that RORβ obviously enhanced
downstream luciferase activity, while co-transfection with
NRIP2 significantly weakened its transcription activity
(Fig. 6f and g). NRIP2 could not activate the Wnt activity
in HBP1-silencing cells (Fig. 6h). Western blots revealed
that the Wnt pathway was activated in HBP1 knockdown
cells (Fig. 6i and j). These HBP1 knockdown cells were in-
oculated into NOD/SCID mice, and they exhibited signifi-
cantly increased tumorigenicity (Fig. 6k). The in vitro
colosphere-formation potential was also enhanced in these
cells (Fig. 6l and m). However, both Wnt activation and
the number of colospheres decreased in cells with
Fig. 5 RORβ inhibits tumorigenesis and the self-renewal of CCICs. a RORB expression in colorectal cancer cells. RORB mRNA and protein expression
levels were detected in colorectal cancer cells by Taqman RT-qPCR and western blotting, respectively. RORB mRNA was normalized with GAPDH. b
RORβ expression in primary colorectal cancer tissues. RORβ expression in human primary colorectal cancer tissues was detected by IHC staining with
antibodies against RORβ. Normal rabbit IgG was used as a negative control. c RORB mRNA in primary colorectal cancer tissues. RORB mRNA was
measured by Taqman RT-qPCR in 14 patients with colorectal cancer. The results showed that the levels of RORB in colorectal cancer cells were
significantly lower than those in matched adjacent tissues. *p < 0.05 (ANOVA). d Tumorigenicity of RORβ-overexpressing cells. RORβ- overexpressing
SW620 cells (1 × 106) as well as their control cells infected with blank lentivirus were injected into naked Balb/c mice, respectively (n = 5). Tumor
formation was quantified within 4 weeks. *p < 0.05 (ANOVA). The results showed that RORβ inhibited tumor growth. e Quantification of colospheres in
RORβ-overexpressing cells. Colospheres were counted in RORβ-overexpressing P1 and control cells infected with blank lentivirus at the 5th day under
low-adhesion and serum-free condition. The number of colospheres significantly decreased after RORβ overexpression compared with the controls.
*p < 0.05 (ANOVA). f Determination of the percentage of CD44 + CD24+ cells after overexpression of RORβ. The percentage of CD44 + CD24+ cells
were analyzed by FCM in RORβ-overexpressing HT29, P1 and SW620 cells, with cells infected with blank lentivirus as controls. The results showed that
RORβ reduced the percentage of CD44 + CD24+ cells compared with the control cells, all p < 0.05 (ANOVA). g RORβ expression in RORB-knockdown
cells. Cells were infected with lentivirus encoding RORB shRNA for 72 h and subsequently screened with 5 μg/mL Puromycin for 7 days. The surviving
cell clone was picked out with limiting dilution analyses. RORβ was detected by western blotting in these RORB-knockdown clones, with cells infected
with scrambled shRNA lentivirus as controls. h Quantification of colospheres in RORB-knockdown cells. Colospheres from the above RORB-knockdown
colorectal cancer cell clones were counted at day 5 under serum-free conditions. The number of colospheres was significantly higher in RORB-knockdown
cells than in the control cells. *p< 0.05 (ANOVA)
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Fig. 6 HBP1 is a crucial target of RORβ in regulation of the Wnt pathway. a Altered mRNA in RORβ-overexpressing cells. SGC7901 cells were transiently
transfected with RORB/pReceiver and control pReceiver plasmids for 24 h. Total RNA was purified for global cDNA GeneChip scanning. The most significant
up-regulated genes are listed. b Detection of HBP1 in RORβ-overexpressing cells. HBP1 was detected by western blotting in cells overexpressing RORβ. P1
cells infected with blank lentivirus and SGC7901 cells transfected with pReceiver plasmids were used as controls c Detection of HBP1 in RORB-knockdown
cells. HBP1 was detected by western blotting in RORB-knockdown cells that were produced by infection with RORB shRNA lentivirus. HBP1 expression was
significantly decreased after knockdown of RORB. P1 and SGC7901 cells infected with scrambled shRNA lentivirus were used as controls. d ChIP analysis of
the interaction between RORβ and HBP1 upstream DNA. DNA fragments were immunoprecipitated by anti-myc-tag antibodies agarose in RORβ-
overexpressing SGC7901 cells after sonication. PCR was used for the detection of the HBP1 upstream DNA sequence. The results showed that RORβ
bound with the region upstream of HBP1 DNA. Blank, normal mouse IgG was used as a negative control, and anti-RNA polymerase II was used as a
positive control. e RORβ binds to hormone response elements (HRE) upstream of the HBP1 promoter region. An EMSA assay was used to identify the
seed region for RORβ binding within upstream hormone response elements of the HBP1 promoter region. Three mutants containing different
potential binding sequences were constructed. The results showed that the hormone response element sequence AGGTCA is essential for
RORβ binding with the HBP1 promoter region. f HRE increased the activity of the promoter. Plasmids containing HRE or the promoter of HBP1
were co-transfected into 239 T cells for 24 h. Luciferase activity was evaluated by the dual-luciferase reporter assay system. The results showed
that HRE increased the HBP1 promoter activity, ***p< 0.001 (ANOVA). pRL3 plasmids were used as a control. g NRIP2 attenuated RORβ transactivation. The
luciferase activity of the HBP1 promoter was determined in 293 T cells at 24 h after co-transfection of RORB and/or NRIP2 as well as in
pRL3 plasmids containing HRE and the HBP1 promoter. The results showed that NRIP2 attenuated RORβ transactivation, ***p< 0.001 (ANOVA). Blank pRL3
plasmids were used as a control. h NRIP2 could not activate Wnt activity in HBP1-silenced cells. Wnt activity was evaluated by a luciferase activity assay in
HBP1-silenced cells and scrambled P1 and SGC7901 cells (control) 24 h after co-transfection with Top/Fop flash reporters and NRIP2 plasmids. The results
showed that NRIP2 could not activate Wnt activity in cells after silencing HBP1. ***p< 0.001 (ANOVA). i Detection of HBP1 in HBP1-knockdown cells. HBP1
was detected by western blotting in the SGC7901 cells with knockdown of HBP1 by shRNAs. SGC7901 cells transfected with scrambled shRNAs as a control.
jWnt activity in HBP1-knockdown cells. c-Myc and cyclin D1 were detected by western blotting in the above HBP1-knockdown and scrambled SGC7901
cells. k Tumorigenicity of HBP1-knockdown cells. HBP1-knockdown SGC7901 cells and their control cells infected with blank lentivirus were injected into
naked Balb/c mice, respectively. Tumor formation was quantified within 4 weeks. The results showed that silence of HBP1 significantly
increased tumorigenicity (p < 0.05, Multivariate logistic analysis). l HBP1 expression in HBP1-knockdown colorectal cancer cells. Colorectal
cancer cells were infected with HBP1 shRNA lentivirus for knockdown of HBP1. HBP1 was detected by western blotting in these HBP1-knockdown and
scrambled colorectal cancer cells (control).m Quantification of colospheres in HBP1-knockdown cells. Colospheres were counted in HBP1-knockdown and
scrambled cells. The number of colospheres was significantly increased in HBP1-knockdown cells. **p< 0.01 (ANOVA). n Detection of the Wnt downstream
targets in HBP1-overexpressing cells. c-Myc and cyclin D1 were analyzed by western blotting in HBP1-overexpressing and control (transfected
with pCMV-XL4 plasmids) P1 cells. o Quantification of colospheres in HBP1-overexpressing cells. The number of colospheres was counted in the above
HBP1-overexpressing and control cells. The results showed that HBP1 significantly inhibited colosphere formation. *p < 0.05 (ANOVA)
Wen et al. Molecular Cancer  (2017) 16:20 Page 11 of 14
reinforced HBP1 expression (Fig. 6n and o). In summary,
these data suggested that the interactions between NRIP2,
RORβ, and HBP1 regulated Wnt pathway activation and
the self-renewal of CCICs.
Discussion
Using a retroviral library screening strategy, we demon-
strated increased expression of NRIP2 in CCICs. NRIP2
was shown to be a novel interactor with the Wnt path-
way. RORβ was identified as a key target of NRIP2,
through which NRIP2 regulates the activity of the Wnt
pathway. The NRIP2-RORβ interaction reduces HBP1
transcription, thereby attenuating HBP1-dependent in-
hibition of the TCF4-DNA complex, finally promoting
the self-renewal of CCICs by up-regulating Wnt path-
ways (Fig. 7).
NRIP2 belongs to the aspartic protease family [34]. Un-
like other members of this family, such as Ddi1, both the
ubiquitin-associated domain and the ubiquitin-like binding
domain are absent from the NRIP2 sequence, suggesting
that NRIP2 has a different function from the other aspartic
protease family members [35]. NIX1, a murine NRIP2
homolog, can bind directly to the C-terminal ligand-
binding domain (LBD) of mouse RORβ independently of
retinoic acid and thyroid hormone T3 to inhibit the tran-
scriptional activity of RORβ. NIX1 was found to participate
in transcriptional repression in yeast cells [30], but the
mechanism whereby NRIP2 regulates the Wnt activity and
the self-renewal of cancer initiating cells has been rarely
reported.
Previously, RORB was primarily detected by Northern
blotting, the expression of which was restricted to the
central nervous system, in particular, to regions involved
in modulating circadian rhythms, such as the suprachias-
matic nucleus, the pineal gland, and the retina [31, 32].
Recently, RORβ was detected in tissues outside of the
nervous system, such as normal bone tissue, the endomet-
rium and pancreatic cancer [36–38]. RORB, which had a
high expression level in the endometrium in healthy pre-
or post-menopausal women, was significantly down-
regulated in endometrial cancer cells [38]. We detected
RORβ expression in normal intestinal epithelial cells and
intestinal tumors; moreover, RORB was also decreased in
cancer tissues, suggesting that the distribution of RORβ
may be more widespread than is currently known and that
RORβ may play a role as a tumor suppressor. Similar to
RORα and RORγ, RORβ contains 4 functional domains,
including an amino-terminal A/B domain, a DNA-binding
domain (DBD), a hinge region, and a carboxy-terminal
LBD [39, 40]. The DBD is highly homologous between
RORβ and RORγ (92%), but the LBD is not well conserved
among RORs [41]. RORβ includes RORβ1 and RORβ2
isoforms. RORβ1 and RORβ2 are characterized by differ-
ent A/B domains that contain 2 and 13 amino acids,
respectively. The N-terminal 2nd–13th amino acids of
RORβ1 are replaced by an arginine in RORβ2 [42]. The
molecular function of RORβ needs to be further clarified.
RORβ is considered to be a critical transcription factor
regulating rod differentiation [43, 44]. RORβ1 induces the
expression of the early key transcription factors Ptf1a and
Foxn4 and promotes the differentiation of amacrine and
horizontal cells [45]. RORβ also regulates bone formation
by inhibiting Runx2 activity [36]. There is relatively little
evidence supporting a functional relationship between the
RORβ and Wnt activities related to the self-renewal of
CCICs. It has been reported that RORα binds to the pro-
moter region of CTNNB1 to inhibit Wnt activity [46],
which is involved in a non-canonical Wnt pathway.
Among the target molecules of NRIP2, RORβ is homolo-
gous to RORα [42, 47], but whether RORβ affects the
Wnt pathway remains unclear. Here, we show that RORβ
suppresses the Wnt pathway and unlike RORα, RORβ nei-
ther binds with β-catenin nor affects its transcription.
RORβ is a DNA transcription enhancer. Thus, we
screened for target genes at the transcriptional level, enab-
ling the discovery of HBP1 as an interaction partner.
RORβ enhances the transcription of HBP1 by binding to
its HRE region upstream promoter. HBP1 belongs to the
sequence-specific, HMG family of transcription factors
[48]. As a putative suppressor of the Wnt pathway, HBP1
may also inhibit the transcription of TCF4 targets by dir-
ectly blocking the binding of TCF4 with DNA [33, 49].
Therefore, we speculate that RORβ may affect the activity
of the Wnt pathway by regulating HBP1 transcription,
Fig. 7 Illustration of interaction between NRIP2, RORβ, and HBP1
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and NRIP2 up-regulates Wnt activity by attenuating
RORβ transcriptional activity. Due to the critical role of
the Wnt pathway in CCIC self-renewal, HBP1 also partici-
pated in the regulation of CCIC self-renewal. These results
indicate that the NRIP2/RORβ/HBP1 pathway is a benefi-
cial supplement to the Wnt pathway. In addition to the
activation of the Wnt pathway by NRIP2/RORβ/HBP1,
NRIP2 is also associated with DNA mismatch repair in
colorectal cancer cells, and RORβ may be correlated with
tumorigenesis and tumor stages (Additional file 2), sug-
gesting that the NRIP2/RORβ/HBP1 pathway is also
involved in other biological processes.
Conclusion
In this study, we identified NRIP2 as a novel molecule
acting in Wnt pathway. The interaction between NRIP2
and RORβ activates downstream target HBP1 and is
probably involved in CCIC self-renewal. For the positive
role in Wnt, NRIP2 may be a potential alternative target
for inhibiting CCIC self-renewal.
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